5-amino-1mq nnmt snp rsid 5mg & 50mg | Inhibitor Research Compound 5A-1-Molecule (5 Amino 1mq) 50mg

GHK-Cu topical: 1 %3 % for skin, 0.5 % for scalp AHK-Cu topical: 0.05 %0.1 % is standard in most hair serums - note this is much lower than GHK-Cu percentages Injectable AHK-Cu: less well characterised

The dose is usually 1,000 mcg

In women undergoing fertility treatments, a potentially life-threatening complication is ovarian hyperstimulation syndrome (OHSS), characterized by rapid weight gain, abdominal pain, ascites, and electrolyte imbalances

It was previously available through compounding pharmacies as a bulk drug substance, but the FDA reclassified it as a Category 2 substance, which effectively restricts compounding pharmacies from producing it